These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28108584)

  • 1. Astrocytic transporters in Alzheimer's disease.
    Ugbode C; Hu Y; Whalley B; Peers C; Rattray M; Dallas ML
    Biochem J; 2017 Feb; 474(3):333-355. PubMed ID: 28108584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive Astrocytes as Drug Target in Alzheimer's Disease.
    Assefa BT; Gebre AK; Altaye BM
    Biomed Res Int; 2018; 2018():4160247. PubMed ID: 29888263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.
    Salcedo C; Wagner A; Andersen JV; Vinten KT; Waagepetersen HS; Schousboe A; Freude KK; Aldana BI
    Neurochem Res; 2021 Oct; 46(10):2676-2686. PubMed ID: 33710537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
    Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC
    Neurobiol Aging; 2013 Oct; 34(10):2341-51. PubMed ID: 23643146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte dysfunction in Alzheimer disease.
    Acosta C; Anderson HD; Anderson CM
    J Neurosci Res; 2017 Dec; 95(12):2430-2447. PubMed ID: 28467650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of the pore-forming K
    Griffith CM; Xie MX; Qiu WY; Sharp AA; Ma C; Pan A; Yan XX; Patrylo PR
    Neuroscience; 2016 Nov; 336():81-101. PubMed ID: 27586053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.
    Avila-Muñoz E; Arias C
    Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes: Glutamate transport and alternate splicing of transporters.
    Lee A; Pow DV
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1901-6. PubMed ID: 20883814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease.
    Scott HA; Gebhardt FM; Mitrovic AD; Vandenberg RJ; Dodd PR
    Neurobiol Aging; 2011 Mar; 32(3):553.e1-11. PubMed ID: 20416976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 in astrocytes of the lateral superior olive.
    Stephan J; Friauf E
    Glia; 2014 Dec; 62(12):1992-2003. PubMed ID: 25103283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of astrocytes to Alzheimer's disease.
    Birch AM
    Biochem Soc Trans; 2014 Oct; 42(5):1316-20. PubMed ID: 25233409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug transporters at brain barriers: expression and regulation by neurological disorders.
    Ashraf T; Kis O; Banerjee N; Bendayan R
    Adv Exp Med Biol; 2012; 763():20-69. PubMed ID: 23397618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte adaptation in Alzheimer's disease: a focus on astrocytic P2X7R.
    Beltran-Lobo P; Reid MJ; Jimenez-Sanchez M; Verkhratsky A; Perez-Nievas BG; Noble W
    Essays Biochem; 2023 Mar; 67(1):119-130. PubMed ID: 36449279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin.
    Sheean RK; Lau CL; Shin YS; O'Shea RD; Beart PM
    Neuroscience; 2013 Dec; 254():335-46. PubMed ID: 24095695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes and neuroinflammation in Alzheimer's disease.
    Phillips EC; Croft CL; Kurbatskaya K; O'Neill MJ; Hutton ML; Hanger DP; Garwood CJ; Noble W
    Biochem Soc Trans; 2014 Oct; 42(5):1321-5. PubMed ID: 25233410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
    Lan YL; Zou S; Chen JJ; Zhao J; Li S
    Neural Plast; 2016; 2016():4626593. PubMed ID: 27057365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
    Szablewski L
    J Alzheimers Dis; 2017; 55(4):1307-1320. PubMed ID: 27858715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Amino Acid Profile and Enzymatic Activity in Adult Rat Astrocyte Cultures.
    Souza DG; Bellaver B; Hansel G; Arús BA; Bellaver G; Longoni A; Kolling J; Wyse AT; Souza DO; Quincozes-Santos A
    Neurochem Res; 2016 Jul; 41(7):1578-86. PubMed ID: 26915106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice.
    Peters O; Schipke CG; Philipps A; Haas B; Pannasch U; Wang LP; Benedetti B; Kingston AE; Kettenmann H
    J Alzheimers Dis; 2009; 18(1):177-89. PubMed ID: 19584439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.
    Sekar S; McDonald J; Cuyugan L; Aldrich J; Kurdoglu A; Adkins J; Serrano G; Beach TG; Craig DW; Valla J; Reiman EM; Liang WS
    Neurobiol Aging; 2015 Feb; 36(2):583-91. PubMed ID: 25448601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.